Combined intratumor cisplatinum injection and Nd:YAG laser therapy

Laryngoscope

Volumn 109, Issue 3, 1999, Pages 447-454

  Graeber, Ines P ^a   Eshraghi, Adrien A ^c   Paiva, Marcos B ^b   Paek, Woo H ^b   Castro, Dan J ^b   Jovanovic, Sergije ^a   Scherer, Hans ^a   Soudant, Jacques ^c   Saxton, Romaine E ^b  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CISPLATIN;

ADULT; ADVANCED CANCER; ARTICLE; CASE REPORT; DRUG EFFICACY; FIBER OPTICS; FOLLOW UP; HEAD AND NECK CANCER; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERTHERMIA; LASER SURGERY; MALE; NEODYMIUM LASER; PALLIATIVE THERAPY; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; TUMOR RECURRENCE;

EID: 0033055576     PISSN: 0023852X     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005537-199903000-00020     Document Type: Article

References (17)

1. Kusomoto T, Holden SA, Ara G, et al. Hyperthcrmia and platinum complexes: time between treatments and synergy in vitro and in vivo. Int J Hyperthermia 1995;11:575-586.
2. Kitamura K, Kuwano H, Matsuda H, et al. Synergistic effects of intratumor administration of cis-diamminedichloroplatinum (II) combined with local hyperthermia in melanoma bearing mice. J Surg Oncol 1992;51:188-194.
3. Yano T, Nakatani K, Watanabe A, et al. Additive effects of cepharantin in CDDP/hyperthermia combination therapy against transplantable human esophageal cancer in nude mice. Int J Radiat Oncol Biol Phys 1994;29(3):525-528.
4. Uehara M, Inokuchi T, Sano K. Experimental study of combined hyperthermic and photodynamic therapy on carcinoma in the mouse. J Oral Maxillofac Surg 1996;54: 729-736.
5. Hettinga JV, Konings AW, Kampinga HH. Reduction of cellular cisplatin resistance by hyperthermia: a review. Int J Hyperthermia 1997;13(5):439-457.
6. Fahy AK, Waldow SM. Evaluation of changes in oxygen tension as indicators of RIF-1 tumor response to Nd:YAG laser heating. Lasers Surg Med 1993;13:312-320.
7. Waldow SM, Russell GE, Wallner PE. Microprocessor-controlled Nd:YAG laser for hyperthermia induction in the RIF-1 tumor. Lasers Surg Med 1992;12:417-424.
8. Castro DJ, Saxton RE, Lufkin RB, et al. Imaging-guided palliative therapy of head and neck carcinomas: proceedings of the Fourth International Conference on Head and Neck Cancer. Am Soc Head Neck Surg 1996;4:189-196.
9. Graeber IP, Paiva MB, Eshraghi AA, et al. Anthrapyrazoles and interstitial laser phototherapy for experimental treatment of squamous cell carcinoma. Laryngoscope 1998; 108(3): 351-357.
10. Paiva MB, Saxton RE, Vander Werf QM, Graeber IP, et al. Cisplatinum and interstitial KTP laser therapy for advanced head and neck cancer: a preclinical study. Lasers Surg Med 1997;21: 423-431.
11. Zanke BW, Boudreau K, Rubie E, et al. The stress-activated protein kinase pathway mediates cell death following injury induced by cis-platinum, UV irradiation or heat. Curr Biol 1996;6:606-613.
12. Miyahara T, Ueda K, Akaboshi M, et al. Hyperthermic en hancement of cytotoxicity and increased uptake of cis-diamminedichloroplatinum (II) in cultured human esophageal cancer cells. Jap J Cancer Res 1993;84(3):336-340.
13. Beketic-Oreskovic L, Jaksic M, Oreskovic S, et al. Hyperthermic modulation of resistance to cis-diamminedichloroplatinum (II) in human larynx carcinoma cells. Int J Hyperthermia 1997;13(2):205-214.
14. Hettinga JV, Lemstra W, Meijer C, et al. Hyperthermic potentiation of cisplatin toxicity in a human small cell lung carcinoma cell line and a cisplatin resistant subline. Int J Hyperthermia 1994;10(6):795-805.
15. Burris, HA III, Vogel CL, Castro D, et al. Intratumoral cisplatin/epinephrine-injectable gel as a palliative treatment for accessible solid tumors: a multicenter pilot study. Otolaryngol Head Neck Surg 1998;118:496-503
16. Davidson BS, Izzo F, Cromees DM, et al. Collagen matrix cisplatinuin prevents local tumor growth after margin-positive resection. J Surg Res 1995;58:618-624.
17. Yu NY, Orenberg EK, Luck EE. Antitumor effect of intratumoral administration of fluorouracil/epinephrine injectable gel in C3H mice. Cancer Chemother Pharmacol 1995;36:27-34